COPD Severity Tied to Life Expectancy - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

COPD Severity Tied to Life Expectancy

A pooled US cohort study estimated years of life lost across airflow obstruction severity, including among adults who never smoked.

  • By

  • Kathryn Wighton

  • June 10, 2026

  • 5 min

Share

Objective:

To analyze the association between chronic obstructive pulmonary disease (COPD) severity and life expectancy.

Approach:
    Key Findings:
    • Include specific mortality rates: 29 per 1,000 person-years for GOLD stage 1, 42 for stage 2, 68 for stage 3, and 115 for stage 4.
    Interpretation:

    Remove this section.

    Limitations:
    • COPD and severity were based on baseline spirometry, not updated during follow-up.
    • The study could not account for incident COPD or medication use.
    • Smoking status was self-reported and assessed only at baseline.
    • Estimates in older age groups may be affected by survivor bias.
    Conclusion:

    Revise to state that the study highlights the association without implying causation.

    Sources:

Original Source(s)

COPD Severity Tied to Life Expectancy

  • by Kathryn Wighton

  • June 10, 2026

Related Content

Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards

Trump’s tobacco investments and industry donations coincided with FDA moves that benefited major nicotine companies.

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.